Nuvalent reports Q4 2025 results, awaits FDA decision on zidesamtinib Feb 26, 2026 06:31AM
Nuvalent Outlines Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2025 Financial Results Feb 26, 2026 06:30AM
Nuvalent completes $500 million stock offering with underwriters' option Nov 24, 2025 04:01PM
Nuvalent Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares from Selling Stockholders Nov 24, 2025 04:01PM
Nuvalent prices $500 million stock offering at $101 per share Nov 18, 2025 11:50PM


Nov 18, 2025 11:50PM Nuvalent Announces Pricing of Public Offering of Common Stock
Nov 17, 2025 04:01PM Nuvalent announces $500 million public stock offering
Nov 17, 2025 04:01PM Nuvalent Announces Public Offering of Common Stock
May 8, 2025 07:31AM Nuvalent Outlines Recent Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2025 Financial Results
Feb 28, 2025 06:30AM Nuvalent to Participate in Upcoming March Investor Conferences
Sep 18, 2024 04:05PM Nuvalent Announces Closing of Upsized Public Offering of Common Stock
Sep 17, 2024 06:15AM Nuvalent Inc (NUVL) Prices Upsized 5M Share Offering at $100/sh
Sep 16, 2024 10:23PM Nuvalent Announces Pricing of Upsized Public Offering of Common Stock
Sep 16, 2024 08:57AM TD Cowen Reiterates Buy Rating on Nuvalent (NUVL)
Sep 16, 2024 07:02AM Nuvalent (NUVL) Announces Public Offering of Common Stock
Sep 16, 2024 07:00AM Nuvalent Announces Public Offering of Common Stock
May 9, 2024 06:31AM Nuvalent Inc (NUVL) Reports Q1, Highlights Pipeline Progress
May 9, 2024 06:30AM Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results
Feb 27, 2024 06:32AM Nuvalent Inc (NUVL) Issues Pipeline Update
Feb 27, 2024 06:30AM Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results
Oct 17, 2023 05:26AM Nuvalent Inc (NUVL) Prices 5.36M Share Offering at $56/sh
Oct 16, 2023 09:55PM Nuvalent Announces Pricing of Public Offering of Common Stock
Oct 16, 2023 07:30AM Nuvalent Inc (NUVL) Announces Proposed $300M Share Offering
Oct 16, 2023 07:30AM Nuvalent Announces Public Offering of Common Stock
May 24, 2023 06:30AM Nuvalent to Participate in the TD Cowen 4th Annual Oncology Innovation Summit
Mar 1, 2023 06:30AM Nuvalent to Participate in the 43rd Annual Cowen Healthcare Conference
Nov 3, 2022 08:13PM Nuvalent Announces Closing of Upsized Public Offering of Common Stock
Nov 1, 2022 05:53AM Nuvalent (NUVL) Prices 6.87M Share Offering at $33.50/sh
Oct 31, 2022 09:14PM Nuvalent Announces Pricing of Public Offering of Common Stock
Oct 31, 2022 07:15AM Nuvalent Inc (NUVL) Announces $200M Public Offering of Common Stock
Oct 31, 2022 07:15AM Nuvalent Announces Public Offering of Common Stock
Mar 2, 2022 06:30AM Nuvalent to Participate in the Cowen 42nd Annual Healthcare Conference
Aug 23, 2021 05:34AM UPDATE: Cowen Starts Nuvalent (NUVL) at Outperform
Aug 2, 2021 05:39PM Nuvalent Announces Closing of Upsized Initial Public Offering
Jul 29, 2021 12:23PM Nuvalent (NUVL) IPO Opens 6% Higher
Jul 29, 2021 05:53AM Nuvalent Inc (NUVL) Prices 9.75M Share IPO at $17/sh
Jul 28, 2021 11:22PM Nuvalent Announces Pricing of Initial Public Offering
Jul 22, 2021 06:13AM Nuvalent Inc (NUVL) Files for up to $100M IPO
Jul 7, 2021 06:22AM Nuvalent Inc. (NUVL) Files Up to $100M IPO